Mass primaquine treatment to eliminate vivax malaria: Lessons from the past

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Kondrashin, Anatoly ^a   Baranova, Alla M ^a   Ashley, Elizabeth A ^b,c   Recht, Judith ^b   White, Nicholas J ^b,c   Sergiev, Vladimir P ^a  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^b MAHIDOL UNIVERSITY   (Thailand)

^c CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Elimination; Eradication; Glucose 6 phosphate dehydrogenase deficiency; Malaria; Mass drug administration; Primaquine; USSR

Indexed keywords

HEMOGLOBIN; PRIMAQUINE;

AFGHANISTAN; AGE DISTRIBUTION; ARTICLE; AZERBAIJAN; BACKACHE; DIZZINESS; DRUG EFFICACY; EPIDEMIC; EYE JAUNDICE; FATIGUE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEADACHE; HEALTH CARE DELIVERY; HEMOLYTIC ANEMIA; HUMAN; INCUBATION TIME; INFECTION PREVENTION; MALARIA CONTROL; NORTH KOREA; PARASITE TRANSMISSION; PATIENT COMPLIANCE; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PREVALENCE; RASH; RETICULOCYTOSIS; RURAL AREA; SEASONAL VARIATION; SEX RATIO; TAJIKISTAN; UNSPECIFIED SIDE EFFECT; URBAN AREA; URINARY TRACT DISEASE; URINE COLOR; VECTOR CONTROL;

ANEMIA, HEMOLYTIC; ANTIMALARIALS; ASIA; CHEMOPREVENTION; DISEASE ERADICATION; DRUG THERAPY; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; MALARIA, VIVAX; PRIMAQUINE;

EID: 84896712523     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-51     Document Type: Article

References (44)

1. Malaria eradication: is it possible? Is it worth it? Should we do it? Liu J, Modrek S, Gosling RD, Feachem RG, Lancet Global Health 2013 1 2 e3 10.1016/S2214-109X(13)70002-0
2. Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Beutler E, Blood 2008 111 16 24 10.1182/blood-2007-04-077412 18156501
3. Glucose-6-phosphate dehydrogenase deficiency. Cappellini MD, Fiorelli G, Lancet 2008 371 64 74 10.1016/S0140-6736(08)60073-2 18177777
4. Glucose-6-Phosphate Dehydrogenase Deficiency (chapter 17). Luzzatto L, Poggi V, Nathan and Oski's hematology of infancy and childhood Canada: Saunders, Orkin, 7 2009
5. G6PD deficiency: global distribution, genetic variants and primaquine therapy. Howes RE, Battle KE, Satyagraha AW, Baird JK, Hay SI, Adv Parasitol 2013 81 133 201 23384623
6. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, Gupta S, Warn P, Allsopp CE, Gilbert SC, Peschu N, Newbold CI, Greenwood BM, Marsh K, Hill AVS, Nature 1995 376 246 249 10.1038/376246a0 7617034
7. Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians. Louicharoen C, Patin E, Paul R, Nuchprayoon I, Witoonpanich B, Peerapittayamongkol C, Casademont I, Sura T, Laird NM, Singhasivanon P, Quintana-Murci L, Sakuntabhai A, Science 2009 326 1546 1549 10.1126/science.1178849 20007901
8. Radical cure of infections with Plasmodium cynomolgi: a function of total 8-aminoquinoline dose. Schmidt LH, Fradkin R, Vaughan D, Rasco J, Am J Trop Med Hyg 1977 26 1116 1128 413444 (Pubitemid 8260922)
9. Determinants of relapse periodicity in Plasmodium vivax malaria. White NJ, Malar J 2011 10 297 10.1186/1475-2875-10-297 21989376
10. Studies on the Plasmodium vivax relapse pattern in Delhi, India. Adak T, Sharma VP, Orlov VS, Am J Trop Med Hyg 1998 59 175 179 9684649 (Pubitemid 28304818)
11. From malaria control to eradication: The WHO perspective. Mendis K, Rietveld A, Warsame M, Bosman A, Greenwood B, Wernsdorfer WH, Trop Med Int Health 2009 14 802 809 10.1111/j.1365-3156.2009.02287.x 19497083
12. The safety of 8-aminoquinoline antimalarials (a review compiled for the WHO Primaquine Evidence Review Group). Recht J, Ashley EA, White NJ, World Health Organization 2013 in press
13. Single dose primaquine as a gametocytocide in Plasmodium falciparum malaria; Updated WHO Policy Recommendation. World Health Organization, Geneva: WHO 2012
14. Mass administrations of antimalarial drugs. von Seidlein L, Greenwood BM, Trends Parasitol 2003 19 452 460 10.1016/j.pt.2003.08.003 14519583 (Pubitemid 38366142)
15. Plasmoquine in malaria; a review of recent experiences. Editorial, Lancet 1931 2 535 537
16. Achieving malaria elimination and certification in Turkmenistan. Shamuradova L, Alieva S, Kurdova-Mintcheva R, Rietveld A, Cibulskis R, Ejov M, Karrieva B, Newman RD, Malar J 2012 11 suppl 1 011 10.1186/1475-2875-11-S1-P11
17. Changes in malaria incidence after mass drug administration in Nicaragua. Garfield RM, Vermund SH, Lancet 1983 2 500 503 6136655 (Pubitemid 13040011)
18. World Health Organization, WHO Expert Committee on Malaria. Seventeenth report Geneva: WHO 1977
19. Widespread use of primaquine for control of Plasmodium vivax epidemics in a population with varying degrees of G6PD deficiency] (in Russian). Kondrashin AV, Baranova AM, Sergiev VP, Med Parazitol (Mosk) 2010 4 24 28 21400709
20. [The system of anti malaria measures towards containment of large scale malaria epidemic in Azerbaijan and its efficacy] (in Russian). Lysenko AY, Actual Problems of Malaria Prevention in the USSR Baku: Ministry of Public Health of the USSR and Ministry of Public Health of Azerbaijan SSR (Soviet Socialist Republic) 1973 70 77
21. [Favism in Lenkoran, Azerbaijan] (in Russian). Djavadov RB, Proceedings of Maharadze Institute Tbilisi: Ministry of Public Health of Georgia SSR 1967 235 239
22. [Glucosephosphate dehydrogenase deficiency among the population of Tadjik SSR] (in Russian). Voronov AA, Aksionova GA, Problemi Gematologii Iperelivaniya Krovi 1981 26 16 21.23
23. Epidemiological role of the deficiency of G6PD in P. vivax malaria in Azerbaijan] (in Russian). Abrashkin-Guchkov RG, Rybalka VM, Koshelev BA, Suleimanov GD, Veinstein AM, Considerations for Malaria Prevention in Azerbaijan SSR Moscow USSR: Ministry of Public Health 1979 67 73
24. [Justification and evaluation of intermittent course of primaquine treatment among population with high frequency of the G6PD deficiency] (in Russian). Lysenko AY, Alexeeva MI, Gorbunova JP, Actual Problems of Malaria Prevention in the USSR Baku: Ministry of Public Health of Azerbaijan SSR 1973 98 103
25. [Prevalence of the G6PD deficiency in Azerbaijan and its malariogenic significance] (in Rusian). Alexeeva MI, Abrashkin-Guchkov RG, Lysenko AY, Gorbunova YP, Glazunova ZI, Mirsiabov AY, Davidova MA, Alekperova SM, Zeinalov IA, Musaev EA, Actual Problems of Malaria Prevention in the USSR Baku: Ministry of Public Health of Azerbaijan SSR 1973 91 97
26. Malaria situation in Azerbaijan SSR in 1970-76. Characteristics and evaluation of the efficacy of anti malaria measures aimed at the malaria eradication in the republic] (in Russian). Chagin KP, Yarotzki LS, Kondrashin AV, Kassatski AI, Alexeev AN, Jukova TA, Gozodova GE, Considerations for Malaria Prevention in Azerbaijan SSR Moscow: Ministry of Public Health of the USSR 1979 6 12
27. [Efficacy of the MPPT during the final stage of malaria eradication in Azerbaijan SSR] (in Russian). Rybalka VM, Veinstein AM, Koshelev BA, Abrashkin-Guchkov RG, Zeinalov IA, Considerations for Malaria Prevention in Azrbaijan SSR Moscow: Ministry of Public Health of the USSR 1979 37 43
28. [Comparative assessment of two schemes of primaquine treatment in Azerbaijan] (in Russian). Gadjiev IA, Abdullaev CI, Bagirov GA, Vahabov EF, Ahmedov AA, Saipphudin K, Wyss K, Actual Problems of Malaria Moscow 1988 84 89
29. [Clinical importance of hemolysis in the prophylactic treatment of malaria using primaquine on persons with a glucose-6-phosphate dehydrogenase deficit] (in Russian]. Bronshtein AM, Ozeretskovskaia NN, Benediktov II, Ibragimov GI, Dzhafarova S, Med Parazitol (Mosk) 1975 44 282 288 1177819
30. [Problem of malaria and antimalarial measures in northern Afghanistan. 2. Topographical malariological districting of northern Afghanistan and the restructuring of the system of antimalarial measures] (in Russian). Polevoi NI, Artem'ev MM, Nushin MK, Iakubi G, Lopukhina NG, Med Parazitol (Mosk) 1975 44 338 344 1177826
31. Buck AA, Anderson RL, Kawata K, Abrahams IW, Ward RA, Sasaki TT, Health and Disease in rural Afghanistan Baltimore: York press 1972 108 110
32. [Problem of malaria and malaria control measures in northern Afghanistan. 4. Results of the examinations of the population of northern Afghanistan for glucosephosphate dehydrogenase deficiency] (in Russian). Saenko GP, Polevoi NI, Ermishev Iu V, Pivnenko VG, Med Parazitol (Mosk) 1977 46 188 190 927346 (Pubitemid 8069258)
33. Prevalence and molecular basis of glucose-6-phosphate dehydrogenase deficiency in Afghan populations: implications for treatment policy in the region. Leslie T, Moiz B, Mohammad N, Amanzai O, Ur Rasheed H, Jan S, Siddiqi AM, Nasir A, Beg MA, Vink M, Malar J 2013 12 230 10.1186/1475-2875-12-230 23834949
34. [Genetic heterogeneity of hereditary enzymopathies] (in Russian). Krasnopolskaia KD, Bochkov NP, Vestn Akad Med Nauk SSSR 1982 9 56 64 7148122
35. An update on the prevalence of glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Tehran neonates. Abolghasemi H, Mehrani H, Amid A, Clin Biochem 2004 37 241 244 10.1016/j.clinbiochem.2003.11.010 14972648 (Pubitemid 38221574)
36. Frequency of malaria and glucose-6-phosphate dehydrogenase deficiency in Tajikistan. Rebholz CE, Michel AJ, Maselli DA, Saipphudin K, Wyss K, Malar J 2006 5 51 10.1186/1475-2875-5-51 16780577 (Pubitemid 44211708)
37. [Efficacy of case detection in Punj district of Tadjik SSR] (in Russian). Efremov SB, Bespyatov VF, Maruzoev KD, Mirzoev KD, Actual Problems of Malaria Moscow: Ministry of Public Health of the USSR 1988 73 79
38. Aliev SP, Malaria epidemic in Tadjikistan, development of scientifically based measures for malaria prevention and control Moscow: IM Sechenov Moscow Medical Academy PhD dissertation. 2005
39. Mass drug administration for the control and elimination of Plasmodium vivax malaria: an ecological study from Jiangsu province, China. Hsiang MS, Hwang J, Tao AR, Liu Y, Bennett A, Shanks GD, Cao J, Kachur SP, Feachem RG, Gosling RD, Gao Q, Malar J 2013 12 383 10.1186/1475-2875-12-383 24175930
40. [Malaria situation and evaluation on the control effect in Henan Province during 1990-2005] (in Chinese). Liu XZ, Xu BL, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2006 24 226 229 17094630
41. World Health Organization, WHO Expert Committee on Malaria Geneva: WHO Fourteenth Report. 1968
42. Kondrashin AV, Assignment report on a visit to the Democratic People's Republic of Korea WHO/SEARO 2006
43. The course of experimentally induced hemolytic anemia in a primaquine-sensitive Caucasian. A case study. Pannacciulli I, Tizianello A, Ajmar F, Salvidio E, Blood 1965 25 92 95 14255977
44. Primaquine sensitivity in Caucasians: hemolytic reactions induced by primaquine in G-6-PD deficient subjects. George JN, Sears DA, McCurdy PR, Conrad ME, J Lab Clin Med 1967 70 80 93 6027097